---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-244185"
form_type: "8-K"
ticker: "OACC"
cik: "0002029769"
company_name: "Oaktree Acquisition Corp. III Life Sciences"
filed_at: "2024-10-25T23:59:59+00:00"
generated_at: "2026-05-30T10:11:14.382565+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oaktree Acquisition Corp. III Life Sciences prices $175M IPO at $10/unit

## Summary
- Gross proceeds of $175M from 17.5M units at $10.00 each; units trade on Nasdaq as OACCU.
- Each unit comprises one Class A share and 1/5 redeemable warrant exercisable at $11.50.
- Underwriters have 45-day over-allotment option for up to 2.625M additional units.
- Sponsor purchased 550,000 private placement units at $10 each, generating $5.5M.
- Net proceeds held in trust for initial business combination; 24-month deadline to complete.

## SEC filing metadata
- accession: 0001193125-24-244185
- form_type: 8-K
- ticker: OACC
- cik: 0002029769
- company_name: Oaktree Acquisition Corp. III Life Sciences
- filed_at: 2024-10-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2029769/000119312524244185/0001193125-24-244185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2029769/000119312524244185/d847969d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-244185
- JSON: https://secwatch.observer/filing/0001193125-24-244185.json
- Plain text: https://secwatch.observer/filing/0001193125-24-244185.txt

## Key facts
- Governance Changes
  Oaktree Acquisition Corp. III Life Sciences: Adopted Amended and Restated Memorandum and Articles of Association in connection with IPO (effective 2024-10-23).
  - Change: charter amendment
  - Effective: 2024-10-23
  source text: On October 23, 2024 and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2029769/000119312524244185/0001193125-24-244185-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.